Skip to main content
. 2019 Apr 17;12:2931–2936. doi: 10.2147/OTT.S199931

Table 1.

Detection of HER2-related biomarkers before treatment

Tumor source HER2 amplification HER2 V777L (AF, %)
Left breast lesion Negative 40.9
Liver lesion Negative
ctDNA Negative 33.85

Abbreviations: AF, allelic frequency; ctDNA, circulating tumor DNA; HER2, human epidermal growth factor receptor 2.